Bullous Pemphigoid Antibiotic Therapy With Doxycycline
Doxycycline is an accepted anti-inflammatory antibiotic option for bullous pemphigoid, most often for localized or mild disease, and is supported by a British Association of Dermatologists guideline as an anti-inflammatory antibiotic strategy (strength of recommendation D, level of evidence 4). [1] A randomized trial strategy used doxycycline 200 mg orally once daily as an initial treatment approach for bullous pemphigoid. [2]
Guideline Role in Treatment Selection
For localized or mild bullous pemphigoid, anti-inflammatory antibiotics are recommended as alternatives or adjuncts to very potent topical corticosteroids. [1] Doxycycline is specifically listed as 200 mg/day within the anti-inflammatory antibiotic treatment options in the guideline treatment-choice table. [1]
Recommended Dosing Regimen
Doxycycline dosing for bullous pemphigoid is recommended as 200 mg per day given orally as a single daily dose. [1], [2] The regimen used in the initial-treatment randomized trial was doxycycline 200 mg/day taken as a single daily dose (brand not specified). [2]
Key Evidence Supporting Doxycycline Use
A pragmatic randomized controlled trial (BLISTER) compared an initial strategy of doxycycline 200 mg/day versus oral prednisolone 0.5 mg/kg/day for bullous pemphigoid. [2] The British Association of Dermatologists guideline specifically cites an RCT comparing doxycycline 200 mg/day with prednisolone as the initial treatment strategy. [1]
Treatment Sequencing and Common Combination
Anti-inflammatory antibiotics are recommended together with very potent topical corticosteroids applied to lesional skin for localized or mild disease when topical therapy is feasible. [1] For disease not responding to existing treatment or relapse on unacceptably high doses, guideline-directed escalation or addition of systemic agents is recommended rather than relying on antibiotic therapy alone. [1]
Practical Safety and Administration Considerations
Sun-sensitivity is the most common adverse effect reported for doxycycline in bullous pemphigoid education materials, and sun protection is recommended during doxycycline therapy. [3]
Target Outcomes of Therapy
Treatment goals in bullous pemphigoid are reduction of new blister formation, healing of existing blisters and sores, and relief of itch and pain. [3]